Shares of Merck KGaA (ETR:MRK – Get Free Report) rose 0.8% on Thursday. The stock traded as high as €141.10 and last traded at €140.15. Approximately 445,194 shares changed hands during mid-day trading, The stock had previously closed at €139.00.
Merck KGaA Price Performance
The stock has a market cap of $61.39 billion, a P/E ratio of 22.64, a P/E/G ratio of 2.37 and a beta of 0.79. The business has a 50 day simple moving average of €137.31 and a 200-day simple moving average of €129.98. The company has a debt-to-equity ratio of 40.77, a quick ratio of 0.72 and a current ratio of 1.69.
Merck KGaA Company Profile
Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company's Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector. This segment provides drug manufacturers with process development expertise and technologies, such as continuous bioprocessing; testing kits and services; reagents and services; testing solutions that analyze air, water, and soil; and testing and tools, as well as products that help test nutritional value and identify quality inconsistencies.
See Also
- Five stocks we like better than Merck KGaA
- Delta Air Lines Faces a Fuel Crisis—But There’s a Silver Lining
- Is Synopsys Back from the Dead? EDA Leader Inks Deals With Amazon and OpenAI
- MarketBeat Week in Review – 10/05 – 10/09
- Alphabet Introduces Gemini Agent—Can It Trigger a Breakout?
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
